Delivery of bioactive molecules to the mitochondrial genome using a membrane-fusing, liposome-based carrier, DF-MITO-Porter

Biomaterials

Volumn 33, Issue 5, 2012, Pages 1589-1595

  Yamada, Yuma ^a   Harashima, Hideyoshi ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Membrane fusion; MITO Porter; Mitochondria; Mitochondrial DNA (mtDNA); Mitochondrial drug delivery; Mitochondrial gene therapy

Indexed keywords

BIOACTIVE MOLECULES; DUAL FUNCTION; HUMAN DISEASE; INTRACELLULAR TRAFFICKING; LIVING CELL; MEDICAL BENEFITS; MEMBRANE FUSION; MITO-PORTER; MITOCHONDRIAL ACTIVITY; MITOCHONDRIAL DNA (MTDNA); MITOCHONDRIAL DYSFUNCTION; MITOCHONDRIAL GENES; MITOCHONDRIAL GENOMES; MITOCHONDRIAL MEMBRANES; NANOCARRIERS; THERAPEUTIC AGENTS;

CELL MEMBRANES; DIAGNOSIS; DNA; DRUG DELIVERY; GENE THERAPY;

MITOCHONDRIA;

DEOXYRIBONUCLEASE I; LIPOSOME; MITOCHONDRIAL DNA; NANOCARRIER;

ARTICLE; BIOLOGICAL ACTIVITY; CELL ACTIVITY; ENDOSOME; MEMBRANE FUSION; MITOCHONDRIAL GENOME; MITOCHONDRIAL MEMBRANE; PRIORITY JOURNAL;

CELL NUCLEUS; DEOXYRIBONUCLEASE I; DNA, MITOCHONDRIAL; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; ENZYMES, IMMOBILIZED; GENOME, MITOCHONDRIAL; HELA CELLS; HUMANS; INTRACELLULAR SPACE; LIPOSOMES; MEMBRANE FUSION; MICROSCOPY, CONFOCAL; MITOCHONDRIA; NANOPARTICLES; NANOSTRUCTURES;

EID: 83555164614     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.10.082     Document Type: Article

References (37)

1. DiMauro S. Mitochondrial myopathies. Curr Opin Rheumatol 2006, 186:636-641.
2. Holt I.J., Harding A.E., Morgan-Hughes J.A. Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies. Nature 1988, 3316158:717-719.
3. Kagawa Y., Inoki Y., Endo H. Gene therapy by mitochondrial transfer. Adv Drug Deliv Rev 2001, 491-2:107-119.
4. Martin L.J. Mitochondriopathy in Parkinson disease and amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 2006, 6512:1103-1110.
5. Sarzi E., Brown M.D., Lebon S., Chretien D., Munnich A., Rotig A., et al. A novel recurrent mitochondrial DNA mutation in ND3 gene is associated with isolated complex I deficiency causing Leigh syndrome and dystonia. Am J Med Genet A 2007, 1431:33-41.
6. Wallace D.C. Mitochondrial diseases in man and mouse. Science 1999, 2835407:1482-1488.
7. Wallace D.C. The mitochondrial genome in human adaptive radiation and disease: on the road to therapeutics and performance enhancement. Gene 2005, 354:169-180.
8. Goto Y., Nonaka I., Horai S. A mutation in the tRNA(Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature 1990, 3486302:651-653.
9. Shoffner J.M., Lott M.T., Lezza A.M., Seibel P., Ballinger S.W., Wallace D.C. Myoclonic epilepsy and ragged-red fiber disease (MERRF) is associated with a mitochondrial DNA tRNA(Lys) mutation. Cell 1990, 616:931-937.
10. Shanske S., Moraes C.T., Lombes A., Miranda A.F., Bonilla E., Lewis P., et al. Widespread tissue distribution of mitochondrial DNA deletions in Kearns-Sayre syndrome. Neurology 1990, 401:24-28.
11. Mukhopadhyay A., Weiner H. Delivery of drugs and macromolecules to mitochondria. Adv Drug Deliv Rev 2007, 598:729-738.
12. Yamada Y., Harashima H. Mitochondrial drug delivery systems for macromolecule and their therapeutic application to mitochondrial diseases. Adv Drug Deliv Rev 2008, 6013-14:1439-1462.
13. Zhang E., Zhang C., Su Y., Cheng T., Shi C. Newly developed strategies for multifunctional mitochondria-targeted agents in cancer therapy. Drug Discov Today 2011, 163-4:140-146.
14. Mukherjee S., Mahata B., Mahato B., Adhya S. Targeted mRNA degradation by complex-mediated delivery of antisense RNAs to intracellular human mitochondria. Hum Mol Genet 2008, 179:1292-1298.
15. Mahata B., Mukherjee S., Mishra S., Bandyopadhyay A., Adhya S. Functional delivery of a cytosolic tRNA into mutant mitochondria of human cells. Science 2006, 3145798:471-474.
16. Weissig V., D'Souza G.G., Torchilin V.P. DQAsome/DNA complexes release DNA upon contact with isolated mouse liver mitochondria. J Control Release 2001, 753:401-408.
17. D'Souza G.G., Rammohan R., Cheng S.M., Torchilin V.P., Weissig V. DQAsome-mediated delivery of plasmid DNA toward mitochondria in living cells. J Control Release 2003, 921-2:189-197.
18. D'Souza G.G., Boddapati S.V., Weissig V. Mitochondrial leader sequence-plasmid DNA conjugates delivered into mammalian cells by DQAsomes co-localize with mitochondria. Mitochondrion 2005, 55:352-358.
19. Yamada Y., Akita H., Kamiya H., Kogure K., Yamamoto T., Shinohara Y., et al. MITO-Porter: a liposome-based carrier system for delivery of macromolecules into mitochondria via membrane fusion. Biochim Biophys Acta 2008, 17782:423-432.
20. Yasuzaki Y., Yamada Y., Harashima H. Mitochondrial matrix delivery using MITO-Porter, a liposome-based carrier that specifies fusion with mitochondrial membranes. Biochem Biophys Res Commun 2010, 3972:181-186.
21. Yamada Y., Furukawa R., Yasuzaki Y., Harashima H. Dual function MITO-Porter, a nano carrier integrating both efficient cytoplasmic delivery and mitochondrial macromolecule delivery. Mol Ther 2011, 19:1449-1456.
22. Futaki S., Suzuki T., Ohashi W., Yagami T., Tanaka S., Ueda K., et al. Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery. J Biol Chem 2001, 2768:5836-5840.
23. Nakase I., Niwa M., Takeuchi T., Sonomura K., Kawabata N., Koike Y., et al. Cellular uptake of arginine-rich peptides: roles for macropinocytosis and actin rearrangement. Mol Ther 2004, 106:1011-1022.
24. Asoh S., Ohsawa I., Mori T., Katsura K., Hiraide T., Katayama Y., et al. Protection against ischemic brain injury by protein therapeutics. Proc Natl Acad Sci U S A 2002, 9926:17107-17112.
25. Del Gaizo V., Payne R.M. A novel TAT-mitochondrial signal sequence fusion protein is processed, stays in mitochondria, and crosses the placenta. Mol Ther 2003, 76:720-730.
26. Futaki S., Ohashi W., Suzuki T., Niwa M., Tanaka S., Ueda K., et al. Stearylated arginine-rich peptides: a new class of transfection systems. Bioconjug Chem 2001, 126:1005-1011.
27. El-Sayed A., Khalil I.A., Kogure K., Futaki S., Harashima H. Octaarginine- and octalysine-modified nanoparticles have different modes of endosomal escape. J Biol Chem 2008, 28334:23450-23461.
28. Kogure K., Akita H., Yamada Y., Harashima H. Multifunctional envelope-type nano device (MEND) as a non-viral gene delivery system. Adv Drug Deliv Rev 2008, 604-5:559-571.
29. Kogure K., Moriguchi R., Sasaki K., Ueno M., Futaki S., Harashima H. Development of a non-viral multifunctional envelope-type nano device by a novel lipid film hydration method. J Control Release 2004, 982:317-323.
30. Suzuki R., Yamada Y., Harashima H. Efficient cytoplasmic protein delivery by means of a multifunctional envelope-type nano device. Biol Pharm Bull 2007, 304:758-762.
31. Homhuan A., Kogure K., Akaza H., Futaki S., Naka T., Fujita Y., et al. New packaging method of mycobacterial cell wall using octaarginine-modified liposomes: enhanced uptake by and immunostimulatory activity of dendritic cells. J Control Release 2007, 1201-2:60-69.
32. Nakamura Y., Kogure K., Yamada Y., Futaki S., Harashima H. Significant and prolonged antisense effect of a multifunctional envelope-type nano device encapsulating antisense oligodeoxynucleotide. J Pharm Pharmacol 2006, 584:431-437.
33. Yamada Y., Kogure K., Nakamura Y., Inoue K., Akita H., Nagatsugi F., et al. Development of efficient packaging method of oligodeoxynucleotides by a condensed nano particle in lipid envelope structure. Biol Pharm Bull 2005, 2810:1939-1942.
34. Chen Z., Felsheim R., Wong P., Augustin L.B., Metz R., Kren B.T., et al. Mitochondria isolated from liver contain the essential factors required for RNA/DNA oligonucleotide-targeted gene repair. Biochem Biophys Res Commun 2001, 2852:188-194.
35. Taylor R.W., Chinnery P.F., Turnbull D.M., Lightowlers R.N. Selective inhibition of mutant human mitochondrial DNA replication in vitro by peptide nucleic acids. Nat Genet 1997, 152:212-215.
36. Tanaka M., Borgeld H.J., Zhang J., Muramatsu S., Gong J.S., Yoneda M., et al. Gene therapy for mitochondrial disease by delivering restriction endonuclease SmaI into mitochondria. J Biomed Sci 2002, 96(1):534-541.
37. Youle R.J., Narendra D.P. Mechanisms of mitophagy. Nat Rev Mol Cell Biol 2011, 121:9-14.